Outcome probabilities
. | 100 d . | 1 y . | 3 y . | 5 y . |
|---|---|---|---|---|
| Grade II-IV acute GVHD* | 29 (21-37) | - | - | - |
| Chronic GVHD* | - | 11 (6-18) | 12 (7-20) | 13 (7-20) |
| TRM* | 21 (14-29) | 22 (16-31) | 22 (16-31) | 25 (17-33) |
| Progression* | - | 45 (36-54) | 52 (43-61) | 70 (61-76) |
| Progression-free survival† | - | 32 (24-41) | 25 (18-33) | 5 (2-10) |
| Survival† | - | 37 (28-46) | 33 (24-42) | 24 (14-37) |
. | 100 d . | 1 y . | 3 y . | 5 y . |
|---|---|---|---|---|
| Grade II-IV acute GVHD* | 29 (21-37) | - | - | - |
| Chronic GVHD* | - | 11 (6-18) | 12 (7-20) | 13 (7-20) |
| TRM* | 21 (14-29) | 22 (16-31) | 22 (16-31) | 25 (17-33) |
| Progression* | - | 45 (36-54) | 52 (43-61) | 70 (61-76) |
| Progression-free survival† | - | 32 (24-41) | 25 (18-33) | 5 (2-10) |
| Survival† | - | 37 (28-46) | 33 (24-42) | 24 (14-37) |